首页|复方栀子根颗粒联合替诺福韦酯对慢性乙型肝炎患者血清细胞因子水平的影响

复方栀子根颗粒联合替诺福韦酯对慢性乙型肝炎患者血清细胞因子水平的影响

扫码查看
目的:观察复方栀子根颗粒联合替诺福韦酯(TDF)治疗慢性乙型肝炎(CHB)患者的临床疗效及对细胞因子的影响.方法:纳入CHB初治患者80 例,采用临床随机对照研究,除去脱落及剔除病例,共纳入分析75 例(治疗组35 例、对照组40 例).对照组患者给予口服TDF,治疗组患者在对照组基础上加用复方栀子根颗粒,两组患者均在治疗4 周、24 周时比较肝功能(ALT、AST、GGT)变化,在治疗24 周比较病毒学指标(HBV DNA、HBsAg、HBeAg)、细胞因子(IL-6、IL-10、IL-17、IL-23)水平及临床疗效判定.结果:两组患者治疗24 周后肝功能、病毒学指标、细胞因子水平均较治疗前显著降低(P<0.05).组间比较,治疗 4 周后治疗组转氨酶下降水平更低,差异有统计学意义(Z =-2.90,P =0.004;Z =-3.26,P =0.001;Z =-2.24,P =0.025);治疗组24 周时IL-6、IL-23 水平较对照组低,差异有统计学意义(Z =-2.14,P =0.033;Z =-2.10,P =0.036);治疗组总有效率 97.14%(34/35),对照组95.00%(38/40),治疗组总有效率高于对照组(χ2 =9.49,P =0.019);治疗组较对照组不良反应更少,差异有统计学意义(χ2 = 6.19,P =0.044).结论:复方栀子根颗粒联合TDF治疗早期能更快降低转氨酶水平,降低促炎细胞因子水平及提高临床综合疗效优于单用TDF,并减轻临床不良反应.
Impact of combining tenofovir disoproxil fumarate with compound Zhizigen granule on the level of inflammatory cytokines in chronic hepatitis B patients
Objective:To monitor the effects of Zhizigen granules in combination with tenofovir disoproxil fumarate(TDF)on inflammatory cytokines and clinical outcomes treating chronic hepatitis B.Methods:The initial therapy involved 80 individuals with chronic hepatitis B in total.The clinical randomized controlled technique used in this investigation reduces separation and exclusions.Finally,75 patients were analyzed,of whom 35 patients were in the therapy group and 40 patients were in the control group.TDF was administered to the control group,and compound Zhizigen granules were added to the treatment group based on the control group.The differences in liver function(ALT,AST,GGT)between the two groups were compared at the 4th and 24th weeks of therapy.At the 24th week of treatment,the differences in virology markers(HBV DNA,HBsAg,HBeAg),cytokines(IL-6,IL-10,IL-17,IL-23),and clinical effectiveness were compared between the two groups.Results:After receiving therapy for 24 weeks,both groups'liver function,virology index,and cytokine levels were much lower than previously(P<0.05).The analysis of the data across the groups revealed that after four weeks of therapy,the transaminase level in the treatment group was lower and that the difference was statistically significant(Z =-2.90,P =0.004;Z =-3.26,P =0.001;Z =-2.24,P =0.025).The levels of IL-6 and IL-23 in the treatment group fell below those in the control group after 24 weeks of therapy,and this difference was statistically significant(Z =-2.14,P = 0.033;Z =-2.10,P = 0.036).The treatment group′s total effective rate was 97.14%(34/35),higher than the control group′s real effective rate of 95.00%(38/40)(χ2 = 9.49,P = 0.019).Additionally,the treatment group experienced fewer adverse reactions than the control group,and the difference was statistically significant(χ2 =6.19,P = 0.044).Conclusion:In the early stages of treatment,compound Zhizigen granules mixed with TDF can quickly lower transaminase and proinflammatory cytokines levels,increase clinical overall effectiveness more than TDF alone,and decrease clinical side effects.

chronic hepatitis BZhizigen granulecompound Chinese medicineeffectiveness assessmentcytokinetenofovir disoproxil fumarate

张婷、裴晓华、蔡虹、吴剑华、徐振兴、王敏

展开 >

福建中医药大学第二临床医学院(福建 福州,350100)

北京中医药大学厦门医院

慢性乙型肝炎 复方栀子根颗粒 中药复方 疗效观察 细胞因子 替诺福韦

福建省科技厅引导性项目厦门市科技计划厦门市重大科技计划全国老中医药专家学术经验继承工作项目(第七批)

2021D0063502Z201991333502Z20221010国中医药人教函[2022]76号

2024

中西医结合肝病杂志
中国中西医结合学会,湖北中医学院

中西医结合肝病杂志

CSTPCD
影响因子:0.908
ISSN:1005-0264
年,卷(期):2024.34(3)
  • 31